Year All202620252024202320222021202020192018201720162015201420122011 Aug 6, 2026 Ardelyx Reports Second Quarter 2026 Financial Results and Provides Business Update Jul 23, 2026 Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026 May 19, 2026 Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026 May 7, 2026 Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings Apr 30, 2026 Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update Apr 27, 2026 Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF’s Spring Clinical Meetings Apr 23, 2026 Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026 Apr 20, 2026 Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer Apr 16, 2026 Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026 Apr 1, 2026 Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx